AlphaNuBeta3 integrin-binding polypeptide monobodies and their use

Details for Australian Patent Application No. 2002307146 (hide)

Owner University of Rochester

Inventors Koide, Akiko; Dewhurst, Stephen; Miller, Michelle; Koide, Shohei; Richards, Julie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002307146

PCT Number PCT/US02/10763

PCT Pub. Number WO2002/081497

Priority 60/281,481 04.04.01 US

Filing date 4 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 1 February 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/281,481 04.04.01 US

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002307146

1 February 2007 Application Accepted

  Published as AU-B-2002307146

31 May 2007 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307147-Nucleic acid vaccines for prevention of flavivirus infection

2002307145-Chimeric vaccines